Cheryl Gault
Chief Operating Officer at Rapport Therapeutics, Inc.
Net worth: 2 646 $ as of 30/03/2024
Profile
Cheryl Gault is currently the Chief Operating Officer at Rapport Therapeutics, Inc. Her former jobs include being the Head of Sales & Marketing at Genzyme Corp., and the VP of Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. from 2017 to 2019.
She was also the Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023.
Ms. Gault received her undergraduate degree from Boston College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/06/2023 | 827 ( 0.03% ) | 2 646 $ | 30/03/2024 |
Cheryl Gault active positions
| Companies | Position | Start |
|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Chief Operating Officer | 06/09/2023 |
Former positions of Cheryl Gault
| Companies | Position | End |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Chief Operating Officer | 27/07/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/03/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Sales & Marketing | - |
Training of Cheryl Gault
| Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
- Stock Market
- Insiders
- Cheryl Gault
